Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Troyhexol is a topical antiseptic solution developed and marketed by Troikaa Pharmaceuticals. It is primarily composed of chlorhexidine gluconate and ethanol, a combination designed for rapid and persistent antimicrobial activity. Chlorhexidine gluconate, a biguanide antiseptic, acts by binding to the negatively charged microbial cell wall and disrupting the cytoplasmic membrane, leading to leakage of cellular contents. Ethanol complements this by rapidly denaturing proteins and dissolving lipid membranes. Troyhexol is widely used in clinical environments for surgical hand scrubs, pre-operative skin preparation, and general hand disinfection to prevent healthcare-associated infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine gluconate + ethanol.